News: prostate cancer

Movember and SAiGENCI partner on landmark database to drive improvements in prostate cancer care

Movember, the leading global men’s health charity, has partnered with the South Australian immunoGENomics Cancer Institute (SAiGENCI) at the University of Adelaide, to create a transformative database that will help researchers develop strategies for clinicians to personalise decisions about prostate cancer care.

[Read more about Movember and SAiGENCI partner on landmark database to drive improvements in prostate cancer care]

An Dieu Trang Nguyen awarded inaugural David Beale Scholarship in Prostate Cancer Research

[Read more about An Dieu Trang Nguyen awarded inaugural David Beale Scholarship in Prostate Cancer Research]

Unlocking the mysteries of prostate cancer

The SAiGENCI team is creating a comprehensive data repository and applying machine learning to uncover revolutionary insights for prostate cancer treatment and prevention.

[Read more about Unlocking the mysteries of prostate cancer]

ENZAMET shows promise as prostate cancer treatment

The results from the clinical trial of ENZAMET, co-chaired by Professor Christopher Sweeney, Director of the South Australian immunoGENomics Cancer Institute (SAiGENCI) that operates within the University of Adelaide, have been published today in The Lancet Oncology .

[Read more about ENZAMET shows promise as prostate cancer treatment ]